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Background: Insight and illness perception are two concepts of interest in the study of factors related to clinical
outcome in patientswith psychosis. Insight implies a risk of emotional distress for the patient. Illness perceptions,
regardless of their accuracy, might be favorable or not to illness. Literature provides evidence of signiﬁcant
correlates of these factors with clinical outcome, but they are rarely included in a single study.
Objectives: 1) assessing insight and illness perception in a sample of Mexican patients who have experienced
psychosis and, 2) analyzing how insight and illness perception relate to each other and how they relate to clinical
status (i.e., positive, negative, and general psychopathology, depression, and anxiety).
Methods: Sixty-one participants (55.7% females) were recruited from a public psychiatric hospital; insight and
illness perceptions were assessed with the SUMD and the Brief-IPQ, respectively. Clinical status was assessed
with the PANSS, CDS and BAI scales.
Results: Participants showed good insight, favorable illness perceptions for the cognitive and comprehension
dimensions, but unfavorable for the emotional dimension. Clinical status of sample was characterized by mild
symptoms. Poor insight related to positive symptoms and general psychopathology. Cognitive and emotional
perceptions of illness were signiﬁcantly associated to most clinical status parameters, whereas comprehension
showed no signiﬁcant results.
Conclusions: The study not only replicates the signiﬁcant association on insight and illness perception with
clinical outcome, but shows how their patterns of interactions are different, reinforcing the idea that they are
two distinct factors worthy of being habitually acknowledged in research and clinical practice.
© 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Most patientswith schizophrenia report partial or total awareness of
their disorder (Buckley et al., 2007; Jablensky et al., 1992; Lincoln et al.,
2007). In the past, insight used to be approached as either present or not
present; nowadays, amongst the different conceptual lines, it is agreed
that insight is multi-dimensional and varies throughout the illness
course (Buckley et al., 2007; Cooke et al., 2005; Osatuke et al., 2008).
Moreover, although most available measures of insight rely totally or
partially on the clinician’s perspective, it has been recognized that
poor insight may be incoherent or incomplete for many different
reasons which can only be studied through the individual’s personal
narrative (Lysaker et al., 2002; Roe et al., 2008; Tranulis et al., 2009).
Discrepancies between the clinician’s and the patient’s points of view
regarding illness can be approached with standardized insight
measures, nevertheless these methods may not be sensitive enough to
differentiate between proﬁles of narrative insight reﬂecting each
person's cultural background, life experiences, and other social determi-
nants (Lysaker et al., 2009; Roe et al., 2008; Tranulis et al., 2008).de Yucatán, Calle 7, No. 433 por
30. Tel.: +52 999 942 7600;
This is an open access article under tAlthough its dynamic nature challenges research, the literature
regarding its etiology has followed four main models: 1) clinical, poor
insight is either a primary symptom itself or somehow related to
another symptom; 2) neuropsychological, poor insight is due to brain
deﬁciencies; 3) psychological, poor insight is a coping strategy against
distress; and 4) social, insight level is inﬂuenced by the social context
in which it is assessed (i.e., insight is rated by the clinician according
to a perception of the difference between his view and the patients’).
These models are supported by empirical data and are not necessarily
mutually exclusive (Chakraborty and Basu, 2010; Cooke et al., 2005;
Osatuke et al., 2008; Raffard et al., 2008). More recent models suggest
poor insight is shaped and sustained by multiple factors, including
neurocognition (deﬁcits in memory and executive function hinder the
recollection and coherent account of historical events related to illness),
social cognition (processes involved in thinking about social interac-
tions such as theory of mind, emotion processing and attribution),
metacognition (activities involving thinking about thinking, representa-
tions of self and others), and stigma (devaluating beliefs about having a
mental disorder) (Lysaker et al., 2013b). Alongwith these original inter-
pretations a number of innovative integrative treatment approaches
have been proposed, including the use of personal narratives (Lysaker
et al., 2002, 2009, 2013a, 2013b).
Reported clinical correlates of insight are diverse: illness severity,
psychotic symptoms, depression, treatment adherence, functioning,he CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).
34 L. Gómez-de-Regil / Schizophrenia Research: Cognition 2 (2015) 33–38quality of life, violence, competence to consent, impaired social skills,
reduced work performance, increased rates of psychotic relapse, and
risks of suicidal and violent behaviors, among others (Buckley et al.,
2007; Chakraborty and Basu, 2010; Drake, 2008; Segarra-Echebarría
et al., 2010).
There is an apparent direct connection between poor insight and
poor treatment adherence, and, consequently, with poorer outcome
and functioning; although this pattern seems rather unstable in
the long term (Buckley et al., 2007; Lincoln et al., 2007; Segarra-
Echebarría et al., 2010). Psychosocial and pharmacological interventions
have been implemented to improve the patients’ level of insight
(Buckley et al., 2007); nevertheless, the achievement of adequate
insight often poses a different set of problems including demoralization,
hopelessness, depression, low self-esteem and high suicide rates
(Cavelti et al., 2014; Crumlish et al., 2005; Dantas and Banzato, 2007;
Lincoln et al., 2007; Lysaker et al., 2013b; Schwartz and Smith, 2004),
which must be considered. Thus, clinical practice faces a challenging
paradox: higher insight is associated with positive outcomes, such as
better treatment adherence and recovery, and negative outcomes,
such as depression, hopelessness, low self-esteem and low quality of
life. Research has not only replicated this pattern, but also supported
self-stigma, social cognition and metacognition as key moderating
factors (Cavelti et al., 2012b; Lysaker et al., 2007, 2013a, 2013b;Misdrahi
et al., 2014; Schrank et al., 2014).
When experiencing an illness some patients might be at least
partially aware of it whereas others might not; nevertheless, they all
have an appraisal of their health status and behave accordingly. Illness
perceptions, sometimes referred to as beliefs, appraisals, or representa-
tions, refer to thoughts, whether accurate or not, that a patient has
about his health problems (Cavelti et al., 2012a). Cognitive representa-
tion was the ﬁrst proposed dimension of illness perception, involving
beliefs about the cause of the illness, the expected physical conse-
quences, the illness’s emotional or functional effects on life, the extent
to which the patient believes he can recover from it, if recovery will
occur with or without treatment, how the illness and its symptoms
are identiﬁed and named, and ideas about how long it will last (Lau
et al., 1989; Leventhal et al., 1984). Later, the emotional dimension,
which focuses on negative reactions such as fear, anger, and distress,
is added, along with the understanding/comprehension dimension
(Broadbent et al., 2006).
Psychosis, whether perceived as an illness or not, raises the individ-
ual’s beliefs involving not only the acknowledgement of his health, but
also the appraisal of personal and social consequences (Watson et al.,
2006). In the presence of symptoms, patients might recognize that
“something is wrong”, naming it “stress”, “nervousness” or “a period
of difﬁculties”. A patient might even seek and accept treatment by him-
self and still not be willing to acknowledge a mental illness; this might
be due to denial, fear of stigmatization, a limited educational level, or
even to low symptoms severity. Interest in the study of illness percep-
tions in patients with schizophrenia and related psychoses has encour-
aged research from diverse countries such as the United Kingdom
(Freeman et al., 2013; Karatzias et al., 2007; Lobban et al., 2004, 2005;
Shah et al., 2009; Theodore et al., 2012; Watson et al., 2006; Williams
and Steer, 2011), Germany (Cavelti et al., 2012a), Turkey (Güner,
2014), and New Zealand (Sanders et al., 2011), with quantitative
(e.g., Williams and Steer, 2011) as well as qualitative methods
(e.g., Güner, 2014). Results have shown signiﬁcant correlations between
positive and negative psychotic symptoms (Cavelti et al., 2012a; Lobban
et al., 2005), anxiety and depression (Cavelti et al., 2012a; Karatzias
et al., 2007; Lobban et al., 2004, 2005; Watson et al., 2006), functioning
(Lobban et al., 2004), engagementwith treatment (Freeman et al., 2013;
Shah et al., 2009; Williams and Steer, 2011), coping style, satisfaction
with mental health (Lobban et al., 2004), self-esteem (Watson et al.,
2006), and quality of life (Lobban et al., 2004; Theodore et al., 2012).
Although at some point insight and illness perceptionmight overlap,
results suggest that they are two fairly different constructs thus, theywould relate differently to outcome (Cavelti et al., 2012a; Watson
et al., 2006). Nevertheless, they are not usually considered simulta-
neously when performing a research study in psychosis. The present
study aimed at: 1) assessing insight and illness perception in a sample
of Mexican patients who have experienced psychosis and, 2) analyzing
how insight and illness perception relate to each other and how they
relate to measures of clinical status (i.e., positive, negative, and general
psychopathology, depression, and anxiety). It was hypothesized that
the correlations between insight and illness perceptions would be
neither strong (r ≥ 0.70) nor signiﬁcant (p ≤ 0.05). Moreover, clinical
status would show some signiﬁcant (p ≤ 0.05) and at least moderate
(r ≥ 0.40) correlations with insight and illness perception, but the
patterns of associations with these two factors would not be alike.
2. Methods
2.1. Sample
Participants were recruited from a public psychiatric hospital pro-
viding mental health services to anyone in need regardless of place of
residence and medical insurance conditions. Formal authorization and
ethical approval was provided by the Hospital Committees.
Inclusion criteria were: i) age at onset 16–45 years old, ii) a primary
current DSM-IV-TR (American Psychiatric Association, 2000) diagnosis
of schizophrenia or other schizophrenia-spectrum psychotic disorder,
and iii) inhabitant of the city of Merida, where the hospital is located.
Exclusion criteria were: i) a DSM-IV-TR diagnosis of psychosis of affec-
tive, organic, or toxic type (American Psychiatric Association, 2000),
ii) evident intellectual disorder, and iii) inadequate contact information.
Following the above-mentioned criteria, clinical ﬁles were reviewed
resulting in 161 potential cases. Only 103 could be contacted (3 had
passed away, 55 no longer lived in the area or could not be located);
66 (64%) agreed to collaborate.
2.2. Measures
Insight was assessed using the three general items of the Scale of
Unawareness of Mental Disorder (SUMD) (Amador and Strauss, 1990;
Amador et al., 1993; Ruiz et al., 2008): 1) awareness of mental disorder,
2) awareness of achieved effects of medication, and 3) awareness of
social consequences of mental disorder. Higher scores, based on a
scale of 1–5, reﬂect poorer insight.
Illness perception was assessed with the Brief Illness Perception
Questionnaire (Brief-IPQ) (Broadbent et al., 2006; Pacheco-Huergo
et al., 2012). This self-report Likert Scale includes eight items regarding
the three dimensions of illness perception: cognitive representation
(“Illness affects my life”, “Illness will last long”, “I control my illness”,
“Treatment is helpful to my illness”, “I experience severe symptoms
from my illness”); emotional representation (“I am concerned about
my illness”, “Illness affects me emotionally”); and comprehensibility
(“I understand my illness”). Higher scores (1–4) of cognitive and
emotional representations indicate an unfavorable perception of illness,
whereas higher scores of comprehensibility reﬂect satisfactory under-
standing of the disorder.
Current clinical status was assessed with the Positive and Negative
Syndrome Scale (PANSS) (Kay et al., 1987; Peralta and Cuesta, 1994),
which comprises three subscales: positive (7 items), negative (7
items) and general psychopathology (16 items). The severity of 30
symptoms is rated from1 (absent) to 7 (extreme). Additionally, depres-
sion and anxiety were assessed using the Calgary Depression Scale
(CDS) and the Beck Anxiety Inventory (BAI), respectively. The CDS
(Addington et al., 1990, 1992; Ortega-Soto et al., 1994; Sarró et al.,
2004) is a nine-item structured interview scale speciﬁcally developed
to assess depression in schizophrenia patients, in which each item is
scored from 0 (absent) to 3 (severe). A general score (0–27) is obtained
by adding up all item scores. The BAI (Beck et al., 1988; Robles et al.,
Table 1
Descriptive statistics for the total sample (N = 61).
Insight (SUMD) Mean (SD) Poor
insight2
n (%)
Unawareness of mental disorder 1.80 (1.12) 7 (11.5)
Unawareness of achieved effects of medication 1.61 (1.12) 5 (8.2)
Unawareness of social consequences of mental disorder 1.93 (1.34) 8 (13.1)
Illness Perception (Brief-IPQ) Mean (SD) Score
above 2.53
n (%)
Cognitive 2.13 (0.58) 16 (26.3)
Consequences 2.75 (1.16) 35 (57.4)
Timeline 2.21 (1.21) 24 (39.3)
Personal control1 3.18 (0.98) 47 (77.0)
Treatment control1 3.51 (0.89) 51 (83.6)
Identity 2.38 (1.25) 31 (50.8)
Emotional 2.50 (1.05) 38 (62.3)
Concern 2.64 (1.25) 33 (54.1)
Emotions 2.36 (1.17) 30 (49.2)
Comprehension 2.85 (1.14) 39 (63.9)
Clinical Status Mean
(SD)
Score
range
PANSS positive (7 items) 1.45 (0.52) 1.00–2.86
PANSS negative (7 items) 1.67 (0.75) 1.00–3.71
PANSS general (16 items) (including item 12: insight) 1.55 (0.42) 1.00–2.75
PANSS general (15 items) (excluding item 12: insight) 1.53 (0.41) 1.00–2.67
Depression (CDS) 3.08 (3.94) 0–18
Anxiety (BAI) 31.62 (11.07) 21–75
SUMD: Scale of Unawareness of Mental Disorder; Brief-IPQ: Brief Illness Perception
Questionnaire; PANSS: Positive and Negative Syndrome Scale; CDS: Calgary Depression
Scale; BAI: Beck Anxiety Inventory.
1 Item score was reversed to add total dimension score; values in table for individual
items are from unreversed scores.
2 Poor insight was considered if SUMD item score was 4 or 5 in a scale from 1 to 5.
3 In a scale from 1 to 4 the mid-point is 2.5; higher cognitive and emotional scores are
unfavorable, higher comprehensibility scores are favorable.
Table 2
Association of insight with illness perception (N = 61).
Unawareness of
mental disorder
Unawareness of
achieved effects
of medication
Unawareness of
social consequences
of mental disorder
Cognitive − .08 .05 − .17
Consequences − .07 − .05 − .13
Timeline − .17 .02 − .02
Personal control1 − .16 − .10 − .21
Treatment control1 − .28* − .48*** − .22
Identity − .15 − .16 − .43***
Emotional .02 .13 .05
Emotion − .03 .04 .03
Concern .05 .18 .05
Comprehension − .26* − .17 − .34**
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Signiﬁcant results in bold.
1 Item score was reversed to add total dimension score; values in table for individual
items are from unreversed scores.
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port the extent to which they feel affected by each of the symptoms,
from 1 (not at all) to 4 (severely). Scores are totaled (from 21 to 84).
2.3. Statistical analysis
Descriptive analyses were performed. On a ﬁrst stage, Spearman’s
two-tailed correlations were used to analyze the association between
insight and illness perception. On a second stage, the association
between clinical status and these two factors was determined.
3. Results
At the time of the assessment, no participants were hospitalized;
nevertheless, ﬁve subjects were excluded due to symptoms severity,
which prevented them from providing reliable answers during the in-
terview. Thus, the ﬁnal sample included 61 participants (55.7% females)
who signed and informed consent with no economic compensation in-
volved. In terms of DSM-IV-TR diagnoses (American Psychiatric Associ-
ation, 2000; First et al., 1995) 41 patients had schizophrenia (14
paranoid, 2 disorganized, and 25 residual) and 20 patients had other
types of schizophrenia-spectrum psychoses (8 schizoaffective, 7 delu-
sional, 2 schizophreniform, 2 brief, and 1 not speciﬁed). Mean illness
course was 6.7 years (SD = 1.9). Current and at onset of psychosis
mean age were 35.9 years (SD = 10.0) and 29.1 years (SD = 9.8), re-
spectively. There were no signiﬁcant sex differences for either current
(t(59) = −1.06, p = 0.29) or onset (t(59) = −1.01, p = 0.32) age.
Thirty-four (55.7%) participants had secondary or lower educational
level (up to 9th grade) and the remaining 27 (44.3%) had partial/
complete medium or higher education. Thirty (49.2%) participants
were single, 26 (42.6%) were married/in union, and 5 (8.2%) were
divorced/separated.
Participants showed good insight; only 5 (8.2%) to 8 (13.1%) people
scored high (4 or 5) in the SUMD dimensions. Overall, illness percep-
tions for cognitive and comprehension dimensions were favorable, but
unfavorable for the emotional dimension. Clinical status of sample
was characterized by mild symptoms as measured by the PANSS, CDS,
and BAI scales. Descriptive data are presented in Table 1.
An analysis of differences in insight, illness perception and clinical
status scores comparing groups by diagnosis, educational level, or hav-
ing a partner, showed no signiﬁcant results in general. Only in the
PANSS negative dimension patients with schizophrenia (t(59) = 3.10,
p ≤ 0.01), lower educational level (t(59) = 2.25, p ≤ 0.05), and without
a partner scored higher (t(59) = 2.12, p ≤ 0.05). Time from onset, cur-
rent age and age at onset showed no signiﬁcant correlationwith insight,
illness perception and clinical status scores. Depression was associated
with older current (r = 0.48, p ≤ 0.001) and onset age (r = 0.47,
p ≤ 0.001).
Data for the association of insight and illness perception are present-
ed in Table 2. Cognitive and emotional perceptions of illness were not
related to any of the three dimensions of insight. Comprehension was
negatively and signiﬁcantly correlated to both, unawareness of mental
disorder and of its social consequences; that is, patients who feel they
understand well their disorder show better insight of illness and its so-
cial effects. Comprehension was not related to insight into medication
effects. A detailed analysis of illness perception items revealed only
three signiﬁcant results: patients perceiving treatment as useful showed
better insight of the disorder (but not of its social consequences) and of
the effects ofmedication, and thosewho see the experienced symptoms
as severe are more aware of the social consequences.
Regarding clinical status (Table 3), higher scores for positive
symptoms and general psychopathology were signiﬁcantly related to
poorer insight (higher unawareness scores). Higher scores on negative
symptomswere related to unawareness of social consequences. Overall,
cognitive and emotional perceptions of illnesswere signiﬁcantly relatedto most clinical status parameters, whereas comprehension showed no
signiﬁcant results.
4. Discussion
Participants showed fairly good levels of insight and favorable
cognitive and comprehension illness perceptions, but emotions towards
illness were unfavorable. From a perspective of lack of insight as a
symptom (Cooke et al., 2005; Osatuke et al., 2008), sample patients’
good overall insight could be attributed to the fact that none of the
participants was in a frank psychotic episode, and those who presented
severe residual symptoms had to be excluded as they could not follow
the interview. Furthermore, it should not be overlooked that positive
Table 3
Association of insight and illness perception with clinical status (N = 61).
Clinical Status Unawareness (SUMD) Illness Perception (Brief-IPQ)
Mental disorder Effects of medication Social consequences Cognitive Emotional Comprehension
PANSS positive .43*** .43*** .44*** .23 .34** − .09
PANSS negative .10 .23 .31* .29* .23 − .11
PANSS general1 .16/.31* .24/.37** .23/.35** .44***/.39** .35**/.34** − .21/− .24
Depression (CDS) .21 .03 .19 .27* .35** − .04
Anxiety (BAI) .24 .23 .16 .49*** .42*** − .23
SUMD: Scale ofUnawareness ofMental Disorder; Brief-IPQ: Brief Illness PerceptionQuestionnaire; PANSS: Positive andNegative Syndrome Scale; CDS: CalgaryDepression Scale; BAI: Beck
Anxiety Inventory.
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Signiﬁcant results in bold.
1 Excluding/Including item 12: Insight.
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ated with all three dimensions of insight, replicating the link between
insight and psychopathology (McEvoy et al., 2006; Mintz et al., 2003,
2004; Mutsatsa et al., 2006), which is not always supported by research
(Hasson-Ohayon et al., 2006; Lincoln et al., 2007; McEvoy et al., 1989).
Results might also concur with the view of lack of insight as a coping
process against distress (Buckley et al., 2007; Cooke et al., 2005; Osatuke
et al., 2008). Insight improves patient’s prognosis but at the same time it
increases psychological distress. The acceptance of having an illness,
particularly inﬂuenced by the stigmatizing beliefs, might explain this
paradox (Lysaker et al., 2007). The association of insight and demorali-
zation seems stronger as self-stigma increases (Cavelti et al., 2012b;
Lysaker et al., 2013a) and patients with good insight accompanied by
stigmatizing beliefs have the highest risk of experiencing low quality
of life, negative self-esteem, and depressed mood (Staring et al.,
2009). As all participants had partial or total symptom remission, that
is, illness was under control, patients might have been more willing to
acknowledge a mental disorder and the beneﬁts of treatment. Yet,
insightwas high and depressionwas low, but theywere not signiﬁcantly
related. Lack of insight could have etiological bases other than denial or
coping, yet they still serve to psychologically protect the individual
from depression (Osatuke et al., 2008); this hypothesis requires
adequate evaluation, unfortunately, data was not sufﬁcient for testing.
Regarding illness perception, in accordance to previous ﬁndings
(Lobban et al., 2005; Theodore et al., 2012), most patients reported fa-
vorable cognitive and comprehension illness perceptions, yet emotions
were unfavorable. Patients feel they understand their illness and recog-
nize the consequences of the disorder and of treatment, and still they
feel emotionally overwhelmed. In professional mental health settings,
patients with psychosis are usually assessed and instructed about
mental illness, its symptoms, treatment and prognosis; unfortunately,
patients’ emotional reactions towards illness are less often explored.
Discussing with patients any possible distress they might be
under due to illness would provide them with a sense of recognition
and would identify possible ideas interfering with treatment.
Giving patients the opportunity to express their beliefs might well
favor their involvement, promoting adherence, self-efﬁcacy, and thus,
a comprehensive outcome.
Results showed that the cognitive and the emotional dimensions
were not related to any of the three dimensions of insight. Patients
reporting comprehension of their illness showed better insight of men-
tal disorder and its social effects, although not of the effects of medica-
tion. Watson et al. (2006) analyzing insight and illness perception
(only the cognitive dimension was assessed) as predictors of treatment
adherence and emotional dysfunction, found these two factorswere not
related, except for global insight and perception of illness as amenable
to cure or control. Cavelti et al. (2012a, 2012b) found that only the cog-
nitive dimension of illness perception (particularly, the identity sub-
scale) was related to insight. All these ﬁndings suggest that, although
insight and illness perception (particularly its cognitive and compre-
hension dimensions) might overlap, they are two distinct constructs,and thus, they must be assessed in parallel. Moreover, the emotional
illness perception seems rather divergent from insight, but still plays
an important role in clinical outcome.
Literature review provided only two previous studies in patients
with psychosis (Cavelti et al., 2012a; Watson et al., 2006) considering
both illness perception and insight as variables, and only the earliest
reported on the association of both factors with psychopathology.
Watson et al. (2006) found cognitive illness perception and insight to
be signiﬁcantly associated with positive symptoms but not to depres-
sion or to anxiety; negative and general psychopathology was not mea-
sured, and the illness perception instrument used included only the
cognitive dimension, though. As for the present study, the cognitive
and the emotional illness perceptionswere the dimensionsmost related
to clinical status, followed by insight into social consequences, whereas
comprehension was not related to any parameter of clinical status.
Exploring possible variables associatedwith clinical outcome in psy-
chosis is a mandatory task for research. Literature supports insight as a
key factor affecting outcome (Chakraborty and Basu, 2010; Drake,
2008), yet criticized for increasing the risk of emotional distress and
for its implicit paternalistic attitude rather reﬂecting the extent to
which individuals agree to biomedical illness models (Cavelti et al.,
2014; Crumlish et al., 2005; Dantas and Banzato, 2007; Lincoln et al.,
2007; Lysaker et al., 2013b; Schwartz and Smith, 2004). Insight, asmea-
sured and promoted by the clinicians’ viewpoint, may not be sufﬁcient
to accomplish clinical targets (e.g., treatment adherence) and, thus, as-
sessment strategies more sensitive to the patient’s perspective, such as
illness perceptions, are needed (Cavelti et al., 2012a). The present
study expands on previous research by analyzing the association of in-
sight and illness perception simultaneously with clinical outcome, and
by providing more speciﬁc data regarding their dimensions. However,
some limitations must be observed. Illness perception assessment re-
quires patients to self-report; therefore, patients whose cognition was
severely affected could not take part in the study, which restricts the
possibility of generalizing results to all patients with psychosis. Insight
was scored by the interviewer, but it has been observed that the pattern
of its association with clinical outcome is not the same if assessed ac-
cording to a patient’s self-rating (Cavelti et al., 2012a). Information re-
garding treatment provision and adherence from onset could not be
recorded; thus, interpretations on factors underlying clinical outcome
cannot be accurately elaborated. Data is insufﬁcient to propose interpre-
tations of theunderlyingmechanisms linking insight and illness percep-
tionwith outcome, an issueworth exploring for further implementation
or emphasis in support programs and interventions. The origin of the
sample may be of concern when discussing the implications of results;
however, research in populations less often studied might serve to
reach a better understanding of patients with psychosis, should previ-
ous ﬁndings be replicated or refuted. Future researchmust not overlook
these limitations and consider objective and subjective, quantitative
and qualitative (e.g., narratives) measures in order to have a better un-
derstanding of the dynamics. Also, the inclusion of patients with other
less stigmatizing mental and/or organic illnesses would be of great
37L. Gómez-de-Regil / Schizophrenia Research: Cognition 2 (2015) 33–38interest, either results are replicated or refuted. Notwithstanding its
limitations, this study not only replicates the signiﬁcant association on
insight and illness perception with clinical outcome, but it shows how
their patterns of interaction are different, reinforcing the idea that
they are two distinct factors that must be acknowledged habitually in
research and clinical practice.
Funding sources
Author was supported by the Consejo Nacional de Ciencia y Tecnología
(CONACyT) with Funding no. 187498 for postgraduate studies.
Contributors
Contributions Dr. Gómez-de-Regil as the solo author was responsi-
ble for protocol and study design, collection and analyses of data, and
the present manuscript as it is.
Conﬂict of interest
Author has no conﬂicts of interest to report.
Acknowledgements
Author thanks the Hospital Psiquiátrico Yucatán (Mexico) for its
support and all those who kindly tool part as participants.
References
Addington, D., Addington, J., Schissel, B., 1990. A depression rating scale for schizo-
phrenics. Schizophr. Res. 3, 247–351.
Addington, D., Addington, J., Maticka-Tyndale, E., Joyce, J., 1992. Reliability and validity of
a depression rating scale for schizophrenics. Schizophr. Res. 6, 201–208.
Amador, X., Strauss, D., 1990. The scale of unawareness of mental disorder. Columbia
University and New York State Psychiatric Institute, New York.
Amador, X., Strauss, D., Yale, S., Flaum, M., Endicott, J., Gorman, J., 1993. Assessment of
insight in psychosis. Am. J. Psychiatry 150, 873–879.
American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental
Disorders. 4th ed. Author, Washington, DC (Text Revision).
Beck, A.T., Epstein, N., Brown, G., Steer, R.A., 1988. An inventory for measuring clinical
anxiety: psychometric properties. J. Consult. Clin. Psychol. 56, 893–897.
Broadbent, E., Petrie, K.J., Main, J., Weinman, J., 2006. The Brief Illness Perception
Questionnaire. J. Psychosom. Res. 60, 631–637.
Buckley, P.F., Wirshing, D.A., Bhushan, P., Pierre, J.M., Resnick, S.A., Wirshing, W.C., 2007.
Lack of insight in schizophrenia: Impact on treatment adherence. CNS Drugs 21,
129–141.
Cavelti, M., Contin, G., Beck, E.-M., Kvrgic, S., Kossowsky, J., Stieglitz, R.-D., et al., 2012a.
Validation of the Illness Perception Questionnaire for Schizophrenia in a German-
speaking sample of outpatients with chronic schizophrenia. Psychopathology 45,
259–269.
Cavelti, M., Kvrgic, S., Beck, E.-M., Rüsch, N., Vauth, R., 2012b. Self-stigma and its relation-
ship with insight, demoralization, and clinical outcome among people with schizo-
phrenia spectrum disorders. Compr. Psychiatry 53, 468–479.
Cavelti, M., Rüsch, N., Vauth, R., 2014. Is living with psychosis demoralizing? Insight, self-
stigma, and clinical outcome among people with schizophrenia across 1 year. J. Nerv.
Ment. Dis. 202, 521–529.
Chakraborty, K., Basu, D., 2010. Insight in Schizophrenia – A comprehensive update. Ger.
J. Psychiatry 13, 17–30.
Cooke, M.A., Peters, E.R., Kuipers, E., Kumari, V., 2005. Disease, deﬁcit or denial? Models of
poor insight in psychosis. Acta Psychiatr. Scand. 112, 4–17.
Crumlish, N., Whitty, P., Kamali, M., Clarke, M., Browne, S., McTigue, O., et al., 2005. Early
insight predicts depression and attempted suicide after 4 years in ﬁrst-episode
schizophrenia and schizophreniform disorder. Acta Psychiatr. Scand. 112, 449–455.
Dantas, C.R., Banzato, C.E.M., 2007. Predictors of insight in psychotic inpatients. Schizophr.
Res. 91, 263–265.
Drake, R.J., 2008. Insight into illness: impact on diagnosis and outcome of nonaffective
psychosis. Curr. Psychiatry Rep. 10, 210–216.
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1995. Structured Clinical Interview
for the DSM-IV Axis I Disorders (SCID). New York State Psychiatric Institute, Biomet-
rics Research, New York.
Freeman, D., Dunn, G., Garety, P., Weinman, J., Kuipers, E., Fowler, D., et al., 2013. Patients’
beliefs about the causes, persistence and control of psychotic experiences predict take-
up of effective cognitive behaviour therapy for psychosis. Psychol. Med. 43, 269–277.
Güner, P., 2014. Illness perceptıon in Turkısh schızophrenıa patıents: A qualıtatıve explor-
atıve study. Arch. Psychiatr. Nurs. http://dx.doi.org/10.1016/j.apnu.2014.08.016.
Hasson-Ohayon, I., Kravetz, S., Roe, D., David, A.S., Weiser, M., 2006. Insight into psychosis
and quality of life. Compr. Psychiatry 47, 265–269.Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., 1992. Schizophrenia: Manifestations, in-
cidence and course in different cultures: A World Health Organization ten-country
study. Psychol. Med. 20, 1–97.
Karatzias, T., Gumley, A., Power, K., O’Grady, M., 2007. Illness appraisals and self-esteem
as correlates of anxiety and affective comorbid disorders in schizophrenia. Compr.
Psychiatry 48, 371–375.
Kay, S.R., Fiszbein, A., Opler, L.A., 1987. The positive and negative syndrome scale (PANSS)
for schizophrenia. Schizophr. Bull. 13, 261–276.
Lau, R.R., Bernard, T.M., Hartman, K.A., 1989. Further explorations of common-sense rep-
resentations of common illnesses. Health Psychol. 8, 195–219.
Leventhal, H., Nerenz, D.R., Steele, D.J., 1984. Illness representations and copingwith health
threats. In: Baum, A., Taylor, S.E., Singer, J.E. (Eds.), Handbookof psychology andhealth.
Social Psychological Aspects of Health vol. IV. Erlbaum, Hillsdale, NJ, pp. 219–252.
Lincoln, T.M., Lüllmann, E., Rief, W., 2007. Correlates and long-term consequences of poor
insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 33,
1324–1342.
Lobban, F., Barrowclough, C., Jones, S., 2004. The impact of beliefs about mental health
problems and coping on outcome in schizophrenia. Psychol. Med. 34, 1165–1176.
Lobban, F., Barrowclough, C., Jones, S., 2005. Assessing cognitive representations of mental
health problems. I. The Illness Perception Questionnaire for Schizophrenia. Br. J. Clin.
Psychol. 44, 147–162.
Lysaker, P.H., Clements, C.A., Plascak-Hallberg, C.D., Knipscheer, S.J., Wright, D.E., 2002. In-
sight and personal narratives of illness in schizophrenia. Psychiatry 65, 197–206.
Lysaker, P.H., Roe, D., Yanos, P.T., 2007. Toward understanding the insight paradox: inter-
nalized stigma moderates the association between insight and social functioning,
hope, and self-esteem among people with schizophrenia spectrum disorders.
Schizophr. Bull. 33, 192–199.
Lysaker, P.H., Buck, K.D., Salvatore, G., Popolo, R., Dimaggio, G., 2009. Lack of awareness of
illness in schizophrenia: conceptualizations, correlates and treatment approaches.
Expert. Rev. Neurother. 9, 1035–1043.
Lysaker, P.H., Vohs, J., Hasson-Ohayon, I., Kukla, M., Wierwille, J., Dimaggio, G., 2013a. De-
pression and insight in schizophrenia: comparisons of levels of deﬁcits in social cog-
nition and metacognition and internalized stigma across three proﬁles. Schizophr.
Res. 148, 18–23.
Lysaker, P.H., Vohs, J., Hillis, J.D., Kukla, M., Popolo, R., Salvatore, G., et al., 2013b. Poor in-
sight into schizophrenia: contributing factors, consequences and emerging treatment
approaches. Expert. Rev. Neurother. 13, 785–793.
McEvoy, J.P., Apperson, L.J., Appelbaum, P.S., Ortlip, P., Brecosky, J., Hammill, K., et al.,
1989. Insight in schizophrenia: Its relationship to acute psychopathology. J. Nerv.
Ment. Dis. 177, 43–47.
McEvoy, J.P., Johnson, J., Perkins, D., Lieberman, J.A., Hamer, R.M., Keefe, R.S.E., et al., 2006.
Insight in ﬁrst-episode psychosis. Psychol. Med. 36, 1385–1393.
Mintz, A.R., Dobson, K.S., Romney, D.M., 2003. Insight in schizophrenia: A meta-analysis.
Schizophr. Res. 61, 75–88.
Mintz, A.R., Addington, J., Addington, D., 2004. Insight in early psychosis: A 1-year follow-
up. Schizophr. Res. 67, 213–217.
Misdrahi, D., Denard, S., Swendsen, J., Jaussent, I., Courtet, P., 2014. Depression in schizophre-
nia: the inﬂuence of the different dimensions of insight. Psychiatry Res. 216, 12–16.
Mutsatsa, S.H., Joyce, E.M., Hutton, S.B., Barnes, T.R.E., 2006. Relationship between
insight, cognitive function, social function and symptomatology in schizophrenia: the
West London ﬁrst episode study. Eur. Arch. Psychiatry Clin. Neurosci. 256, 356–363.
Ortega-Soto, H.A., Gracia-Perales, S., Imaz, B., Pacheco-Patzin, J., Brunner, E., Apiquián, R.,
et al., 1994. Validez y reproductibilidad de una escala para evaluar la depresión en
pacientes esquizofrénicos. Salud Ment. 17, 7–14.
Osatuke, K., Ciesla, J., Kasckow, J.W., Zisook, S., Mohamed, S., 2008. Insight in schizophrenia:
A review of etiological models and supporting research. Compr. Psychiatry 49, 70–77.
Pacheco-Huergo, V., Viladrich, C., Pujol-Ribera, E., Cabezas-Peña, C., Núñez, M., Roura-
Olmeda, P., et al., 2012. Perception in chronic illnesses: linguistic validation of the Re-
vised Illness Perception Questionnaire and the Brief Illness Perception Questionnaire
for a Spanish population. Aten. Primaria 44, 280–287.
Peralta, V., Cuesta, M.J., 1994. Validación de la escala de los Síndromes Positivo y Negativo
(PANSS) en una muestra de esquizofrénicos Españoles. Actas Luso Esp. Neurol.
Psiquiatr. 22, 171–177.
Raffard, S., Bayard, S., Capdevielle, D., Garcia, F., Boulenger, J.-P., Gely-Nargeot, M.-C., 2008.
Lack of insight in schizophrenia: a review. Encéphale 34, 511–516.
Robles, R., Varela, R., Jurado, S., Páez, F., 2001. Versión Mexicana del Inventario de
Ansiedad de Beck: propiedades psicométricas. Rev. Mex. Psicol. 18, 211–218.
Roe, D., Hasson-Ohayon, I., Kravetz, S., Yanos, P.T., Lysaker, P.H., 2008. Call it a monster
for lack of anything else: narrative insight in psychosis. J. Nerv.Ment. Dis. 196, 859–865.
Ruiz, A.I., Pousa, E., Duño, R., Crosas, J.M., Cuppa, S., García-Ribera, C., 2008. Adaptación al
Español de la Escala de Valoración de la No Conciencia de Trastorno Mental (SUMD).
Actas Esp. Psiquiatr. 36, 111–119.
Sanders, D., Kydd, R., Morunga, E., Broadbent, E., 2011. Differences in patients’ perceptions
of schizophrenia betweenMāori and New Zealand Europeans. Aust. N. Z. J. Psychiatry
45, 483–488.
Sarró, S., Dueñas, R.M., Ramírez, N., Arranz, B., Martínez, R., Sánchez, J.M., et al., 2004.
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depres-
sion Scale for Schizophrenia. Schizophr. Res. 68, 349–356.
Schrank, B., Amering,M., Hay, A.G.,Weber, M., Sibitz, I., 2014. Insight, positive and negative
symptoms, hope, depression and self-stigma: a comprehensivemodel of mutual inﬂu-
ences in schizophrenia spectrum disorders. Epidemiol. Psychiatr. Sci. 23, 271–279.
Schwartz, R.C., Smith, S.D., 2004. Suicidality and psychosis: the predictive potential of
symptomatology and insight into illness. J. Psychiatr. Res. 38, 185–191.
Segarra-Echebarría, R., Ojeda-del Pozo, N., Zabala-Rabadán, A., Garcí- Ormaza, J., Peña-Lasa,
J., Eguíluz-Uruchurtu, I., et al., 2010. Insight in ﬁrst episode psychosis: Conceptual and
clinical considerations. Eur. J. Psychiatry 24, 78–86.
38 L. Gómez-de-Regil / Schizophrenia Research: Cognition 2 (2015) 33–38Shah, P., Hull, T., Riley, G.A., 2009. Associations between the Illness Perception Question-
naire for Schizophrenia and engagement in treatment in a secure setting. Clin.
Psychol. 13, 69–74.
Staring, A.B.P., Van der Gaag, M., Van den Berge, M., Duivenvoorden, H.J., Mulder, C.L.,
2009. Stigma moderates the associations of insight with depressed mood, low self-
esteem, and low quality of life in patients with schizophrenia spectrum disorders.
Schizophr. Res. 115, 363–369.
Theodore, K., Johnson, S., Chalmers-Brown, A., Doherty, R., Harrop, C., Ellett, L., 2012.
Quality of life and illness beliefs in individuals with early psychosis. Soc. Psychiatry
Psychiatr. Epidemiol. 47, 545–551.Tranulis, C., Corin, E., Kirmayer, L.J., 2008. Insight and psychosis: comparing the perspec-
tives of patient, entourage and clinician. Int. J. Soc. Psychiatry 54, 225–241.
Tranulis, C.S., Freudenreich, O., Park, L., 2009. Narrative insight: rethinking insight in
psychosis. Int. J. Cult. Ment. Health 2, 16–28.
Watson, P.W.B., Garety, P.A., Weinman, J., Dunn, G., Bebbington, P.E., Fowler, D., et al.,
2006. Emotional dysfunction in schizophrenia spectrum psychosis: The role of illness
perceptions. Psychol. Med. 36, 761–770.
Williams, K., Steer, H., 2011. Illness perceptions: Are beliefs aboutmental health problems
associated with self-perceptions of engagement in people with psychosis? Behav.
Cogn. Psychother. 39, 151–163.
